Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40

70Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

SGN-40 is a therapeutic antibody targeting CD40, which induces potent anti-lymphoma activities via direct apoptotic signalling cells and by cell-mediated cytotoxicity. Here we show antibody-dependent cellular phagocytosis (ADCP) by macrophages to contribute significantly to the therapeutic activities and that the antitumour effects of SGN-40 depend on Fc interactions. © 2009 Cancer Research UK.

Cite

CITATION STYLE

APA

Oflazoglu, E., Stone, I. J., Brown, L., Gordon, K. A., Van Rooijen, N., Jonas, M., … Gerber, H. P. (2009). Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40. British Journal of Cancer, 100(1), 113–117. https://doi.org/10.1038/sj.bjc.6604812

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free